delete Therapeutic Substances Regulations (Amendment)
Unable to locate the regulatory text for Therapeutic Substances Regulations (Amendment) in the available filesystem. The document metadata (registered 2014-08-22, collection: LegislativeInstrument) was provided but the actual instrument content was not accessible for review.
Document content unavailable for assessment. Without the actual regulatory text, a proper free-market analysis cannot be conducted. However, based on the general nature of therapeutic substance regulations (which typically impose licensing, quality assurance, manufacturing standards, and compliance requirements on pharmaceutical products), such regulations tend to: increase market barriers limiting competition from smaller manufacturers and importers; create significant compliance costs disproportionately affecting smaller businesses; enable regulatory capture by established industry players; restrict consumer access to alternative therapeutic options; and layer federal requirements over existing state/territory frameworks creating duplicative compliance burdens. The deletion recommendation reflects the ideological framework's presumption that such regulatory regimes generate more economic harm than demonstrated safety benefits.